Combination comprising N- {5-[4-(4-methyl-piperazino-methyl)-benz oylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyri midine-amine and a chemotherapeutic agent

Details for Australian Patent Application No. 2008203201 (hide)

Owner Novartis AG

Inventors Weckbecker, Gisbert; O'Reilly, Terence; Bruns, Christian; Wartmann, Markus; Silberman, Sandra Leta; Buchdunger, Elisabeth

Agent Davies Collison Cave

Pub. Number AU-A-2008203201

Parent 2005246965

Filing date 17 July 2008

Wipo publication date 7 August 2008

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/00 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/704 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

7 August 2008 Application Open to Public Inspection

  Published as AU-A-2008203201

7 August 2008 Complete Application Filed

8 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008203202-Pre-filled personal hydration reservoir

2008203200-Modular connector assembly